148 related articles for article (PubMed ID: 30644029)
1. The Role of Multiagent Chemoradiation in the Management and Prognosis of Anal Squamous Cell Carcinoma.
Goffredo P; Utria AF; Hrabe JE; Gribovskaja-Rupp I; Kapadia MR; Hassan I
J Gastrointest Surg; 2019 Apr; 23(4):712-719. PubMed ID: 30644029
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive treatment experience of anal squamous cell carcinoma from a tertiary cancer center in South China.
Yuan Y; Xie WH; Li RZ; Chang H; Zeng ZF; Gao YH; Wang QX; Xiao WW
Cancer Med; 2022 Jan; 11(1):117-127. PubMed ID: 34816622
[TBL] [Abstract][Full Text] [Related]
3. Chemoradiation versus local excision in treatment of stage I anal squamous cell carcinoma: A population-based analysis.
Gao X; Goffredo P; Kahl AR; Charlton ME; Weigel RJ; Hassan I
Eur J Surg Oncol; 2020 Sep; 46(9):1663-1667. PubMed ID: 32199768
[TBL] [Abstract][Full Text] [Related]
4. Definitive Pelvic Radiotherapy and Survival of Patients With Newly Diagnosed Metastatic Anal Cancer.
Wang Y; Yu X; Zhao N; Wang J; Lin C; Izaguirre EW; Farmer M; Tian G; Somer B; Dubal N; Schwartz DL; Ballo MT; VanderWalde NA
J Natl Compr Canc Netw; 2019 Jan; 17(1):29-37. PubMed ID: 30659127
[No Abstract] [Full Text] [Related]
5. A Population-Based Cohort Analysis of Chemoradiation Versus Radiation Alone for Definitive Treatment of Stage I Anal Cancer in Older Patients.
Buckstein M; Arens Y; Wisnivesky J; Gaisa M; Goldstone S; Sigel K
Dis Colon Rectum; 2018 Jul; 61(7):787-794. PubMed ID: 29771796
[TBL] [Abstract][Full Text] [Related]
6. Outcomes after intensity-modulated compared with 3-dimensional conformal radiotherapy with chemotherapy for squamous cell carcinoma of the anal canal.
Agarwal MS; Hitchcock KE; Morris CG; George TJ; Mendenhall WM; Zlotecki RA
Curr Oncol; 2019 Aug; 26(4):e515-e521. PubMed ID: 31548820
[TBL] [Abstract][Full Text] [Related]
7. Anal Squamous Cell Carcinoma: Radiation Therapy Alone Must Be Avoided.
Almaazmi H; Taylor JP; Stem M; Yu D; Lo BD; Safar B; Efron JE
J Surg Res; 2020 Mar; 247():530-540. PubMed ID: 31648811
[TBL] [Abstract][Full Text] [Related]
8. Three cytotoxic drugs combined with pelvic radiation and as maintenance chemotherapy for patients with squamous cell carcinoma of the anus (SCCA): long-term follow-up of a phase II pilot study using 5-fluorouracil, mitomycin C and cisplatin.
Sebag-Montefiore D; Meadows HM; Cunningham D; Plowman PN; Hurman DC; Davidson N; Grieve R; Levine E; Glynne-Jones R
Radiother Oncol; 2012 Aug; 104(2):155-60. PubMed ID: 22857859
[TBL] [Abstract][Full Text] [Related]
9. Primary surgery with or without postoperative radiotherapy in early stage squamous cell carcinoma in the anal canal and anal margin.
Leon O; Hagberg O; Johnsson A
Acta Oncol; 2018 Sep; 57(9):1209-1215. PubMed ID: 29490558
[TBL] [Abstract][Full Text] [Related]
10. Current therapeutic strategies for anal squamous cell carcinoma in Japan.
Takashima A; Shimada Y; Hamaguchi T; Ito Y; Masaki T; Yamaguchi S; Kondo Y; Saito N; Kato T; Ohue M; Higashino M; Moriya Y;
Int J Clin Oncol; 2009 Oct; 14(5):416-20. PubMed ID: 19856049
[TBL] [Abstract][Full Text] [Related]
11. Does gap-free intensity modulated chemoradiation therapy provide a greater clinical benefit than 3D conformal chemoradiation in patients with anal cancer?
Dewas CV; Maingon P; Dalban C; Petitfils A; Peignaux K; Truc G; Martin E; Khoury C; Dewas S; Créhange G
Radiat Oncol; 2012 Nov; 7():201. PubMed ID: 23190693
[TBL] [Abstract][Full Text] [Related]
12. Patterns and Predictors of Relapse Following Radical Chemoradiation Therapy Delivered Using Intensity Modulated Radiation Therapy With a Simultaneous Integrated Boost in Anal Squamous Cell Carcinoma.
Shakir R; Adams R; Cooper R; Downing A; Geh I; Gilbert D; Jacobs C; Jones C; Lorimer C; Namelo WC; Sebag-Montefiore D; Shaw P; Muirhead R
Int J Radiat Oncol Biol Phys; 2020 Feb; 106(2):329-339. PubMed ID: 31629837
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Impact of Residual HPV ctDNA Detection after Chemoradiotherapy for Anal Squamous Cell Carcinoma.
Cabel L; Jeannot E; Bieche I; Vacher S; Callens C; Bazire L; Morel A; Bernard-Tessier A; Chemlali W; Schnitzler A; Lièvre A; Otz J; Minsat M; Vincent-Salomon A; Pierga JY; Buecher B; Mariani P; Proudhon C; Bidard FC; Cacheux W
Clin Cancer Res; 2018 Nov; 24(22):5767-5771. PubMed ID: 30054279
[No Abstract] [Full Text] [Related]
14. Chemoradiotherapy with or without consolidation chemotherapy using cisplatin and 5-fluorouracil in anal squamous cell carcinoma: long-term results in 31 patients.
Cho BC; Ahn JB; Seong J; Roh JK; Kim JH; Chung HC; Sohn JH; Kim NK
BMC Cancer; 2008 Jan; 8():8. PubMed ID: 18194582
[TBL] [Abstract][Full Text] [Related]
15. Long-term results of weekly/daily cisplatin-based chemoradiation for locally advanced squamous cell carcinoma of the anal canal.
Eng C; Chang GJ; You YN; Das P; Xing Y; Delclos M; Wolff RA; Rodriguez-Bigas MA; Skibber J; Ohinata A; Gould S; Phillips J; Crane CH
Cancer; 2013 Nov; 119(21):3769-75. PubMed ID: 24037775
[TBL] [Abstract][Full Text] [Related]
16. Combined PET-CT and MRI for response evaluation in patients with squamous cell anal carcinoma treated with curative-intent chemoradiotherapy.
Adusumilli P; Elsayed N; Theophanous S; Samuel R; Cooper R; Casanova N; Tolan DJ; Gilbert A; Scarsbrook AF
Eur Radiol; 2022 Aug; 32(8):5086-5096. PubMed ID: 35274187
[TBL] [Abstract][Full Text] [Related]
17. Role of pelvic chemoradiation therapy in patients with initially metastatic anal canal cancer: A National Cancer Database review.
Abdelazim YA; Rushing CN; Palta M; Willett CG; Czito BG
Cancer; 2019 Jun; 125(12):2115-2122. PubMed ID: 30825391
[TBL] [Abstract][Full Text] [Related]
18. Predictors of Nonadherence to NCCN Guideline Recommendations for the Management of Stage I Anal Canal Cancer.
Kole AJ; Stahl JM; Park HS; Khan SA; Johung KL
J Natl Compr Canc Netw; 2017 Mar; 15(3):355-362. PubMed ID: 28275036
[No Abstract] [Full Text] [Related]
19. Chemoradiotherapy for anal squamous cell carcinoma.
Houlihan OA; O'Neill BD
Surgeon; 2016 Aug; 14(4):202-12. PubMed ID: 27118047
[TBL] [Abstract][Full Text] [Related]
20. Twenty-five-year experience with radical chemoradiation for anal cancer.
Tomaszewski JM; Link E; Leong T; Heriot A; Vazquez M; Chander S; Chu J; Foo M; Lee MT; Lynch CA; Mackay J; Michael M; Tran P; Ngan SY
Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):552-8. PubMed ID: 22019078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]